key: cord-0702450-qga513ql
authors: Watchmaker, Jennifer M; Goldman, Daryl T; Lee, Jun Y; Choi, Seulah; Mills, Ariana C; Toussie, Danielle; Finkelstein, Mark; Sher, Alex R; Jacobi, Adam H; Bernheim, Adam M; Chung, Michael S; Eber, Corey D; Lookstein, Robert A
title: Increased Incidence of Acute Pulmonary Embolism in Emergency Department Patients During the COVID‐19 Pandemic
date: 2020-10-05
journal: Acad Emerg Med
DOI: 10.1111/acem.14148
sha: 63ecf652df22e1df0a06923db7ec7117afb54f46
doc_id: 702450
cord_uid: qga513ql

Early detection of acute pulmonary embolism (PE) in patients with SARS‐CoV‐2 infection is integral to the clinical management of these patients. Many recently published studies have evaluated incidence of PE in hospitalized patients with COVID‐19(1‐9), however there is relatively limited data describing patients with SARS‐CoV‐2 infection and concomitant diagnosis of acute PE upon initial presentation. Therefore, the purpose of this study is to (i) evaluate the incidence of acute pulmonary embolism (PE) in patients undergoing computed tomography pulmonary angiography (CTPA) in the emergency department (ED) across six hospitals in New York City during the height of the COVID‐19 pandemic compared to a non‐pandemic period, and (ii) compare the characteristics and early outcomes of patients presenting with PE during the pandemic (n=87) to patients presenting with PE during a non‐pandemic period (n=34).

Early detection of acute pulmonary embolism (PE) in patients with SARS-CoV-2 infection is integral 2 to the clinical management of these patients. Many recently published studies have evaluated incidence of PE 3 in hospitalized patients with COVID-19 1-9 , however there is relatively limited data describing patients with 4 SARS-CoV-2 infection and concomitant diagnosis of acute PE upon initial presentation. Therefore, the purpose 5 of this study is to (i) evaluate the incidence of acute pulmonary embolism (PE) in patients undergoing 6 computed tomography pulmonary angiography (CTPA) in the emergency department (ED) across six hospitals 7 in New York City during the height of the COVID-19 pandemic compared to a non-pandemic period, and (ii) 8 compare the characteristics and early outcomes of patients presenting with PE during the pandemic (n=87) to 9 patients presenting with PE during a non-pandemic period (n=34).

This retrospective review was approved by the institutional review board and informed written consent 11 was waived. No authors had any conflicts of interest to declare.

The inclusion criteria included all patients 18 years of age who underwent CTPA in the emergency 13 department. Data was collected for all patients who underwent imaging between April 1 st and May 1 st , 2019, 14 and April 1 st and May 1 st , 2020, representing studies performed during non-pandemic and pandemic times, 15 respectively. Demographic information was manually extracted from the electronic medical record with and 16 each record was reviewed by two independent authors for accuracy. Date of testing for SARS-CoV-2 infection 17 by reverse transcriptase polymerase chain reaction (RT-PCR) was recorded. For the purposes of classifying 18 patients as positive, negative, or not tested, the following criteria were used. Patients were classified as COVID 19 positive if the patient had a documented positive test from an encounter prior to presenting to the ED with PE 20 or if the patient had a positive test obtained within 2 days of CTPA. If a patient was not tested or tested 21 negative within 2-days of the CTPA, the patient was classified as not-tested, or negative, respectively. Patients 22 who >2 days after CTPA tested positive, were classified according to results available within 2 days of PE 23 detection.

Outcomes data on each patient was recorded for 14-days following hospital discharge. Patients 25 transferred to an outside hospital after admission were excluded from the short-term outcomes analysis. For the 26 patients diagnosed with PE between April 1 st and May 1 st 2020, date of symptom onset was recorded, with any 27 described symptom of SARS-COV2 infection recorded as day 1 of symptoms 10 .

Axial images from the thoracic inlet to the iliac crests were obtained of the chest during IV 29 administration of an intravenous contrast bolus timed for pulmonary arterial opacification. 3-D and thin section 30 reformats were performed on a separate workstation. Dose reduction techniques were utilized including 31 kVp/mA dose modulation based on patient size and iterative reconstruction. Reports of PE-protocol CTAs 32 performed were queried from the radiology information system using Montage (Montage Health, Monterey, Accepted Article 34 performed in 2020 were additionally evaluated for commonly reported imaging features of COVID-19 35 pneumonia 11 . 36 To compare continuous data between the 2019 and 2020 group a Mann-Whitney U test was used for non-37 normally distributed data, and a student's t -test was used for normally distributed data. Pearson's Chi-squared 38 test was used to compare categorical variables between groups. Normality of continuous data was determined 39 by the Shapiro-Wilk test. Normally distributed data was reported and means with standard deviations, and non-40 normally distributed data was reported as medians with interquartile ranges. All statistical tests were 

There was no significant difference in number of patients who underwent intensive care unit (ICU) 66 admission, length of hospital stay, 14-day readmission, or disposition of the patients between the groups. 67 Detailed characteristics of the cohorts and short-term outcomes are described in the Table. 68 Our study demonstrated that 18.8% of studies performed during the height of the pandemic were 69 positive for PE, which is significantly higher than the year prior in which 7.6% of CTPA studies performed in 70 the ED were positive for PE. Notably, a prior study performed by a single-center in France, reported an 71 incidence of PE of 18.0% in patients presenting to the ED with COVID-19 pneumonia 12 

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Incidence of venous thromboembolism in hospitalized patients with COVID-19

Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence

Coronavirus Disease 2019 in China

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department

This article is protected by copyright. All rights reserved